Arkolith/Insider Trading/ADMP/Form 4

Marguglio David J.

SVP and Chief Business Officer, DirectorAdamis Pharmaceuticals Corp (ADMP) · full profile →Form 4 · filed Dec 3, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$40K
Net Open-Market Flow
-$40K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 1, 2021Sell(S)51K$0.79$40K259K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001387131-21-011776) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML